Bioventus to Report Fourth Quarter of Fiscal Year 2025 Financial Results on March 5, 2026

Core Viewpoint - Bioventus Inc. will report its financial results for the fourth quarter of fiscal year 2025 on March 5, 2026, and will host a conference call to discuss these results and provide a business update [1]. Group 1 - The financial results will be announced before the market opens on March 5, 2026 [1]. - A conference call will take place at 8:30 a.m. Eastern Time on the same day to discuss the results [1]. - Participants can join the conference call by dialing 1-833-636-0497 and referring to the Bioventus Inc. Conference Call [2]. Group 2 - Bioventus is focused on delivering clinically proven, cost-effective products that aid in quick and safe healing [3]. - The company's mission is to help patients resume and enjoy active lives through its innovations in Pain Treatments, Restorative Therapies, and Surgical Solutions [3]. - Bioventus emphasizes high quality standards, evidence-based medicine, and strong ethical behavior, positioning itself as a trusted partner for physicians globally [3].